Ji Zhang

State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study.

VAL-083 is effective in patients with newly-diagnosed MGMT-unmethylated glioblastoma: report of phase II study.

Journal: Discover oncology

Published: July 23, 2025

The tumor-associated fibrotic reactions in microenvironment aggravate glioma chemoresistance.

The tumor-associated fibrotic reactions in microenvironment aggravate glioma chemoresistance.

Journal: Frontiers in oncology

Published: February 20, 2024

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.

Journal: Nature cancer

Published: March 25, 2023

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.

Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.

Journal: JAMA network open

Published: January 27, 2023

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma.

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma.

Journal: Science advances

Published: July 20, 2022

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis.

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis.

Journal: Frontiers in pharmacology

Published: October 29, 2021

MicroRNA-599 suppresses glioma progression by targeting RAB27B.

MicroRNA-599 suppresses glioma progression by targeting RAB27B.

Journal: Oncology letters

Published: August 04, 2021

Identify glioma recurrence and treatment effects with triple-tracer PET/CT.

Identify glioma recurrence and treatment effects with triple-tracer PET/CT.

Journal: BMC medical imaging

Published: March 14, 2021

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas.

Journal: Frontiers in cell and developmental biology

Published: January 14, 2021

IL13RA2 is overexpressed in malignant gliomas and related to clinical outcome of patients.

IL13RA2 is overexpressed in malignant gliomas and related to clinical outcome of patients.

Journal: American journal of translational research

Published: February 17, 2020

Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma.

Pretreatment neutrophil-to-lymphocyte ratio plus albumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade III glioma.

Journal: Annals of translational medicine

Published: January 14, 2020

Tim-3 expression in glioma cells is associated with drug resistance.

Tim-3 expression in glioma cells is associated with drug resistance.

Journal: Journal of cancer research and therapeutics

Published: August 23, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026